Our stories

UMass Chan clinical trial studies psychedelic medication for adjustment disorder related to serious illness

The three grants totaling nearly $8 million were awarded over a six-week period to Fiachra Humphries, PhD.

The Patient-Centered Outcomes Research Institute is sponsoring the two-year, $300,000 project.

Classrooms and labs kept busy this summer at UMass Chan, hosting high school and college students participating in outreach programs.

The R01 grant will support research on how bacteria cause infectious diseases.

FDA approves gene therapy clinical trial for Tay-Sachs and Sandhoff diseases by UMass Chan scientists  

The project is funded for $3.5 million over seven years by the UMass Center for Clinical and Translational Science.

AMP modified vaccine adjunct activates robust T cell response. 

UMass Chan researchers discuss the growing evidence behind acupuncture’s role in modern integrative medicine and how it is helping to reduce chronic pain. 

David D. McManus, MD’02, ScM’12, MBA, has officially stepped into the role of chancellor of UMass Chan.